Most pharmaceutical companies face challenges in becoming compliant with the ISO IDMP standards. In this article, Rune Bergendorff, responsible for NNIT’s ISO IDMP services shares experience from NNIT’s IDMP work for a handful of pharmaceutical companies over the past two years, letting you in on the conclusions from the IDMP Experience Exchange Group where another handful of pharmaceutical companies shared their insights.
https://international-pharma.com/wp-content/uploads/2014/12/ISO-IDMP.pdf
Current Edition
Current Edition
CDMO Subsection
Insights into the latest developments in CDMO services and manufacturing.
Continue readingInjectables Subsection
Expert perspectives on the evolving needs of injectable therapies and packaging.
Continue readingNasal & Pulmonary Subsection
Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability
Continue reading
ISO IDMP – Four Challenges in Preparing Organisations for the July 1, 2016 EMA Deadline
